SQSTM1 and metabolic syndrome: Since chronic inflammation is currently recognized as important contributor in pathogenesis of OA, in particular, in OA-associated pain (30), we hypothesed that p62 plasmid may alleviate signs of OA via anti-inflammatory mechanisms found in our previous studies in osteoporosis and metabolic syndrome (32–34).